Hartmann Taylor Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Sell
391
-23
-6% -$23.3K 0.24% 46
2025
Q4
$445K Hold
414
0.3% 41
2025
Q3
$316K Sell
414
-16
-4% -$11.9K 0.23% 43
2025
Q2
$335K Sell
430
-22
-5% -$17.1K 0.28% 39
2025
Q1
$373K Buy
+452
New +$376K 0.33% 35

Other funds holding LLY

Hartmann Taylor Wealth Management's LLY Position: Q1 2026 in Review

Hartmann Taylor Wealth Management reduced its Eli Lilly (LLY) stake by 5.6% in Q1 2026, selling an estimated $23.3K and leaving 391 shares worth $360K. The position accounts for 0.24% of the portfolio, ranked #46.

Hartmann Taylor Wealth Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $445K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hartmann Taylor Wealth Management held 391 shares of Eli Lilly worth $360K as of Q1 2026.
  • Hartmann Taylor Wealth Management sold 23 Eli Lilly shares in Q1 2026, an estimated $23.3K.
  • Eli Lilly made up 0.24% of Hartmann Taylor Wealth Management's portfolio in Q1 2026, its #46 holding.
  • Hartmann Taylor Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Hartmann Taylor Wealth Management's Eli Lilly position peaked at $445K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hartmann Taylor Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.